A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.
| Autor: | Warso, M A1, Richards, J M2, Mehta, D3, Christov, K1, Schaeffer, C1, Rae Bressler, L4, Yamada, T1, Majumdar, D5, Kennedy, S A6, Beattie, C W1, Das Gupta, T K1 |
|---|---|
| Zdroj: | British Journal of Cancer. 3/19/2013, Vol. 108 Issue 5, p1061-1070. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|